Portfolio (Quarterly)
Guide ↗
Persistent Asset Partners Ltd
· CIK 0002056052| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 181 | — CALL | AQUESTIVE THERAPEUTICS INC | — | 566.0 | $65K | 0.03% | NEW | — | $114.77 | — |
| 182 | — PUT | AQUESTIVE THERAPEUTICS INC | — | 906.0 | $59K | 0.03% | NEW | — | $65.61 | — |
| 183 | TARA | PROTARA THERAPEUTICS INC | Healthcare | 10,733.0 | $57K | 0.03% | NEW | — | $5.33 | -4.7% |
| 184 | — CALL | VANDA PHARMACEUTICALS INC | — | 530.0 | $57K | 0.03% | NEW | — | $107.50 | — |
| 185 | AARD | AARDVARK THERAPEUTICS INC | Healthcare | 4,231.0 | $56K | 0.03% | NEW | — | $13.13 | -62.0% |
| 186 | — PUT | CAPRICOR THERAPEUTICS INC | — | 533.0 | $55K | 0.03% | NEW | — | $104.03 | — |
| 187 | — | CORBUS PHARMACEUTICALS HLDGS | — | 6,587.0 | $54K | 0.02% | NEW | — | $8.14 | — |
| 188 | — PUT | VIKING THERAPEUTICS INC | — | 851.0 | $53K | 0.02% | NEW | — | $61.73 | — |
| 189 | PLRX | PLIANT THERAPEUTICS INC | Healthcare | 38,831.0 | $47K | 0.02% | NEW | — | $1.22 | -5.7% |
| 190 | CDXS | CODEXIS INC | Healthcare | 27,813.0 | $45K | 0.02% | NEW | — | $1.63 | +52.8% |
| 191 | — CALL | REGENERON PHARMACEUTICALS | — | 13.0 | $44K | 0.02% | NEW | — | $3380.23 | — |
| 192 | — | TALPHERA INC | — | 36,630.0 | $42K | 0.02% | NEW | — | $1.14 | — |
| 193 | CMPS | COMPASS PATHWAYS PLC | Healthcare | 5,483.0 | $38K | 0.02% | NEW | — | $6.90 | +56.3% |
| 194 | — PUT | SPDR SERIES TRUST | — | 669.0 | $36K | 0.02% | NEW | — | $54.18 | — |
| 195 | — CALL | EVOLUS INC | — | 318.0 | $33K | 0.01% | NEW | — | $102.50 | — |
| 196 | XBIT | XBIOTECH INC | Healthcare | 13,565.0 | $32K | 0.01% | NEW | — | $2.39 | +2.5% |
| 197 | — | INHIBRX BIOSCIENCES INC | — | 346.0 | $27K | 0.01% | NEW | — | $79.00 | — |
| 198 | — CALL | JANUX THERAPEUTICS INC | — | 80.0 | $26K | 0.01% | NEW | — | $324.96 | — |
| 199 | — PUT | TG THERAPEUTICS INC | — | 265.0 | $24K | 0.01% | NEW | — | $91.32 | — |
| 200 | — CALL | VIR BIOTECHNOLOGY INC | — | 238.0 | $21K | 0.01% | NEW | — | $87.99 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
56.7%
Technology
14.5%
Financial Services
14.2%
Consumer Cyclical
3.6%
Communication Services
3.5%
Energy
3.5%
Basic Materials
3.0%
Consumer Defensive
0.6%
Industrials
0.4%